CD4 and ovarian cancer: In contrast, a study reported that there is a negative correlation between the regulatory T cell activity of CD4+ and CD25+ and the outcome of ovarian cancer patients and that CD4+CD25+FOXP3+Treg cells tend to accumulate primarily in tumors or ascites.